Literature DB >> 19437356

Angiogenesis and pituitary tumors.

Adam B Cohen1, Simmons Lessell.   

Abstract

Pituitary adenomas often first manifest through visual symptoms. They are typically slow-growing and histologically benign tumors, but can become clinically destructive, invade adjacent structures, and recur after treatment. Unlike many other tumors that become aggressive and appear to depend upon angiogenesis in the process, pituitary adenomas tend to do so through non-angiogenic means. This article examines the role of angiogenesis in pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437356     DOI: 10.1080/08820530902805651

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  7 in total

1.  Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.

Authors:  Yu Mei; Wenya Linda Bi; James Agolia; Changchen Hu; Alexandra M Giantini Larsen; David M Meredith; Sally Al Abdulmohsen; Tejus Bale; Gavin P Dunn; Malak Abedalthagafi; Ian F Dunn
Journal:  Pituitary       Date:  2021-01-25       Impact factor: 4.107

2.  Analyses and treatments of postoperative nasal complications after endonasal transsphenoidal resection of pituitary neoplasms.

Authors:  You Cheng; Fei Xue; Tian-You Wang; Jun-Feng Ji; Wei Chen; Zhi-Yi Wang; Li Xu; Chun-Hua Hang; Xin-Feng Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 3.  The Treatment of Refractory Pituitary Adenomas.

Authors:  Congxin Dai; Xiaohai Liu; Wenbin Ma; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-29       Impact factor: 5.555

4.  Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression.

Authors:  Gianina Demarchi; Sofía Perrone; Gaela Esper Romero; Cristian De Bonis; Juan Pablo Casasco; Gustavo Sevlever; Silvia Ines Berner; Carolina Cristina
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

Review 5.  Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System.

Authors:  Federica Barbieri; Stefano Thellung; Roberto Würth; Federico Gatto; Alessandro Corsaro; Valentina Villa; Mario Nizzari; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

6.  A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.

Authors:  Yanming Miao; Miao Zong; Tao Jiang; Xuesen Yuan; Shusen Guan; Yisong Wang; Dabiao Zhou
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

Review 7.  Recent advances in understanding corticotroph pituitary tumor initiation and progression.

Authors:  Ulrich Renner; Denis Ciato; Günter K Stalla
Journal:  F1000Res       Date:  2018-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.